Sign in

You're signed outSign in or to get full access.

Gregory Crawford

Gregory Crawford

Chief Executive Officer at Quipt Home Medical
CEO
Executive
Board

About Gregory Crawford

Gregory J. Crawford, 51, is President, Chief Executive Officer, and Chairman of Quipt Home Medical Corp. (QIPT), serving as a director since December 21, 2017 and as CEO since that date; he resides in Fort Thomas, Kentucky . He is a seasoned healthcare executive with 30+ years’ DME experience focused on operations, integration, and M&A; under his leadership, Quipt expanded from ~$50M to a multi‑hundred‑million‑dollar revenue business through strategy, operational improvements, and acquisitions while emphasizing profitability and margins . The Board combines Chair/CEO roles (Crawford), with Mark Greenberg serving as Lead Independent Director to mitigate independence concerns; a majority of directors are independent . In FY2024 he attended 100% of Board meetings (4/4) .

Past Roles

OrganizationRoleYearsStrategic Impact
Not disclosed in DEF 14AProxy highlights 30+ years of DME leadership in operations, integration, and M&A; specific prior employers not listed .

External Roles

CategoryDetails
Public company boards (current)None disclosed; no QIPT directors are presently directors of other reporting issuers in Canada or the U.S.
Other rolesNot disclosed in DEF 14A

Fixed Compensation

Metric (USD)FY 2023FY 2024
Base Salary$596,540 $680,725
Cash Bonus (actual paid)$302,016 TBD (2024 bonus not determined as of proxy; to be disclosed via 8‑K when set)
Share-based Awards (fair value)$976,701 (RSUs)
Option Awards (fair value)
Other Compensation$26,265 $31,381
Total Compensation$1,901,522 $712,106

Notes: 2024 discretionary cash bonuses, if any, will be determined later and disclosed under Item 5.02(f) of Form 8‑K .

Performance Compensation

ComponentMetricWeightingTargetActual/PayoutVesting/Timing
Annual Cash IncentiveDiscretionary based on annual financial performance and other financial/non‑financial goalsNot disclosed Not disclosed2023 payout: $302,016 cash; 2024 TBD Cash; immediate on award
RSU AwardsService-based (equity alignment under 2024 EIP/legacy plans)Not disclosed 2023 grant fair value: $976,70147,500 RSUs unvested as of 9/30/24; vest per schedule below Two tranches: Nov 20, 2024 and Feb 20, 2025 (equal amounts)
Option AwardsTime-based options outstanding (see Equity Ownership)Not disclosedOutstanding, exercisable; see details below Through stated expirations

Vesting schedules and upcoming supply

  • RSUs: 47,500 unvested as of 9/30/24; vest in equal amounts on Nov 20, 2024 and Feb 20, 2025 .
  • Additional delivery: 95,000 RSUs issuable on or before March 15, 2025 (vested in calendar 2024) .

Equity Ownership & Alignment

ItemDetail
Total Beneficial Ownership (shares)3,703,278 (includes spouse 20,000 and 1,216,832 held by a family trust with partial control)
Percent of Shares Outstanding8.4% (based on 43,091,273 shares outstanding as of Jan 16, 2025)
Options (exercisable / within 60 days)656,000 options (matches 581,000 @ $1.11 exp Apr 9, 2028 and 75,000 @ $6.28 exp May 20, 2031)
RSUs deliverable by Mar 15, 202595,000 (vested in 2024 calendar year)
Unvested RSUs (as of 9/30/24)47,500; vesting Nov 20, 2024 and Feb 20, 2025 (equal amounts)
Shares PledgedNone of these shares are pledged as security
Hedging/Pledging PolicyHedging, shorting, derivatives, margin accounts, and pledging are prohibited by insider trading policy
Stock Ownership GuidelinesNot disclosed in DEF 14A

Outstanding equity awards (detail)

  • Options: 581,000 options at $1.11 expiring Apr 9, 2028; 75,000 options at $6.28 expiring May 20, 2031 .
  • RSUs: 47,500 unvested shares; market value $138,700 at $2.92 as of 9/30/24 .

Employment Terms

TermDetail
Employment AgreementInitial term 3 years starting Nov 1, 2020; auto‑renews for one‑year terms unless earlier terminated
Base Salary in AgreementInitial base salary $525,000 in year 1; 7% increase on each anniversary of commencement
Termination – Without CauseFinal compensation plus severance equal to base salary for remaining period of the term (subject to release)
Change of ControlIf termination within 1 year after CoC: severance equals greater of remaining term or 2× current base salary (subject to release)
Good ReasonExecutive may resign for Good Reason and receive same severance terms as Without Cause (subject to release)
For Cause / Voluntary (no Good Reason) / Death/DisabilityFinal compensation only; no additional severance
Equity on Termination/CoCBoard may accelerate vesting/settlement of outstanding awards, including upon a change in control and related terminations, subject to law and plan terms
ClawbackPolicy adopted in 2023; recoupment of erroneously paid incentive‑based compensation upon financial restatement, regardless of fault

Board Service & Governance

ItemDetail
Board RoleDirector since Dec 21, 2017; Chairman of the Board; CEO
IndependenceNot independent (executive officer); majority of Board is independent
Lead Independent DirectorMark Greenberg
CommitteesNot a member of Audit, Compensation, or Nominating Committees (all independent)
Meeting Attendance (FY2024)Board 4/4; committee N/A
Executive SessionsIndependent directors met in executive session at each of the four Board meetings in FY2024
Director Pay (for Crawford)No additional remuneration for serving as director/Chair

Related Party Transactions (Governance Red Flag)

  • Quipt subsidiaries maintain six market‑rate leases (office/warehouse/retail; 74,520 sq. ft.) with Greg Crawford, LLC, a rental company 100% beneficially owned through a trust over which Gregory Crawford exercises control; five leases renewed in Dec 2022 for seven years (to Sept 30, 2029), one expires June 2026; approx. $65,000 monthly payments with annual increases of the greater of CPI‑U or 3%; aggregate periodic payments due on or after FY2024 start totaled $4,566,725 (and $349,335 for FY2023) .

Compensation Committee Analysis

  • Composition: Kevin Carter (Chair), Brian Wessel, Mark Greenberg; all members independent under NI 52‑110, Nasdaq, and Exchange Act Rule 10C‑1 .
  • Mandate includes CEO goal‑setting and evaluation, setting executive pay, administering incentive plans, reviewing severance/CoC arrangements, risk review of incentives, oversight of shareholder engagement on pay; may engage independent compensation advisors .

Investment Implications

  • Alignment and retention: Crawford owns 8.4% of outstanding shares, with no pledging, and a policy prohibiting hedging/pledging—strong skin‑in‑the‑game signals; severance provides 2× base salary on double‑trigger CoC, supporting retention but creating potential deal‑related cost .
  • Near‑term selling pressure: 95,000 RSUs are scheduled to be issued by March 15, 2025, and 47,500 unvested RSUs vested on Nov 20, 2024 and Feb 20, 2025—potential incremental float/supply to monitor around vesting windows .
  • Pay‑for‑performance transparency: Bonuses are discretionary and metrics/weightings are not disclosed; there were no new equity grants in FY2024 under the 2024 EIP, and 2024 bonus outcomes were TBD as of the proxy—limits visibility into incentive rigor near term .
  • Governance risks mitigated: Combined CEO/Chair role is flagged, but Board maintains a Lead Independent Director, independent committees, executive sessions, and an SEC/Nasdaq‑compliant clawback; however, related‑party leases with entities controlled by Crawford represent a continuing governance overhang to monitor for fairness and Audit Committee oversight .